This inventor holds 1 USPTO granted patent. Top assignee: The University of Tokyo. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Kento Hayashi: Innovator in Anticancer Research
Introduction
Kento Hayashi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of cancer research through his innovative work on prodrug-type anticancer agents. His research focuses on developing novel compounds that can effectively target cancer cells.
Latest Patents
Kento Hayashi holds a patent for a prodrug-type anticancer agent that utilizes cancer-specific enzymatic activity. This patent aims to provide new compounds represented by a general formula, which are promising as prodrug-type anticancer agents. The innovative approach of targeting cancer-specific enzymatic activity is a significant advancement in cancer treatment.
Career Highlights
Hayashi is affiliated with The University of Tokyo, where he conducts his research and development. His work has garnered attention for its potential to improve cancer therapies and enhance patient outcomes. With one patent to his name, he is recognized for his contributions to the scientific community.
Collaborations
Kento Hayashi collaborates with esteemed colleagues, including Yasuteru Urano and Mako Kamiya. These collaborations enhance the research efforts and contribute to the advancement of cancer treatment methodologies.
Conclusion
Kento Hayashi is a dedicated inventor whose work in developing prodrug-type anticancer agents holds promise for the future of cancer treatment. His innovative research and collaborations continue to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile